These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26350900)

  • 1. The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane.
    Loregger A; Grandl M; Mejías-Luque R; Allgäuer M; Degenhart K; Haselmann V; Oikonomou C; Hatzis P; Janssen KP; Nitsche U; Gradl D; van den Broek O; Destree O; Ulm K; Neumaier M; Kalali B; Jung A; Varela I; Schmid RM; Rad R; Busch DH; Gerhard M
    Sci Signal; 2015 Sep; 8(393):ra90. PubMed ID: 26350900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two Wnt-responsive elements in the intron of RING finger protein 43 (RNF43) gene.
    Takahashi N; Yamaguchi K; Ikenoue T; Fujii T; Furukawa Y
    PLoS One; 2014; 9(1):e86582. PubMed ID: 24466159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma.
    Jiang X; Hao HX; Growney JD; Woolfenden S; Bottiglio C; Ng N; Lu B; Hsieh MH; Bagdasarian L; Meyer R; Smith TR; Avello M; Charlat O; Xie Y; Porter JA; Pan S; Liu J; McLaughlin ME; Cong F
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12649-54. PubMed ID: 23847203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
    Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
    J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling.
    Tsukiyama T; Fukui A; Terai S; Fujioka Y; Shinada K; Takahashi H; Yamaguchi TP; Ohba Y; Hatakeyama S
    Mol Cell Biol; 2015 Jun; 35(11):2007-23. PubMed ID: 25825523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rnf43.
    Serra S; Chetty R
    J Clin Pathol; 2018 Jan; 71(1):1-6. PubMed ID: 29018044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-β/catenin signaling pathway.
    Gao Y; Cai A; Xi H; Li J; Xu W; Zhang Y; Zhang K; Cui J; Wu X; Wei B; Chen L
    Stem Cell Res Ther; 2017 Apr; 8(1):98. PubMed ID: 28446252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNF43 R117fs mutant positively regulates Wnt/β-catenin signaling by failing to internalize FZD expressed on the cell surface.
    Cho AR; Sul HJ; Kim YJ; Kim B; Zang DY
    Sci Rep; 2022 Apr; 12(1):7013. PubMed ID: 35487932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor Zic2 inhibits Wnt/β-catenin protein signaling.
    Pourebrahim R; Houtmeyers R; Ghogomu S; Janssens S; Thelie A; Tran HT; Langenberg T; Vleminckx K; Bellefroid E; Cassiman JJ; Tejpar S
    J Biol Chem; 2011 Oct; 286(43):37732-40. PubMed ID: 21908606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
    Zhang Y; Toh L; Lau P; Wang X
    J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.
    Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A
    Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells.
    Ju X; Ishikawa TO; Naka K; Ito K; Ito Y; Oshima M
    Cancer Sci; 2014 Apr; 105(4):418-24. PubMed ID: 24447505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIB2 inhibits Wnt/β-Catenin/TCF4 signaling through its associated ubiquitin E3 ligases, β-TrCP, COP1 and Smurf1, in liver cancer cells.
    Xu S; Tong M; Huang J; Zhang Y; Qiao Y; Weng W; Liu W; Wang J; Sun F
    FEBS Lett; 2014 Nov; 588(23):4334-41. PubMed ID: 25311538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p15RS attenuates Wnt/{beta}-catenin signaling by disrupting {beta}-catenin·TCF4 Interaction.
    Wu Y; Zhang Y; Zhang H; Yang X; Wang Y; Ren F; Liu H; Zhai Y; Jia B; Yu J; Chang Z
    J Biol Chem; 2010 Nov; 285(45):34621-31. PubMed ID: 20739273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.
    Koo BK; Spit M; Jordens I; Low TY; Stange DE; van de Wetering M; van Es JH; Mohammed S; Heck AJ; Maurice MM; Clevers H
    Nature; 2012 Aug; 488(7413):665-9. PubMed ID: 22895187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer.
    Huang S; Fantini D; Merrill BJ; Bagchi S; Guzman G; Raychaudhuri P
    Cancer Res; 2017 Dec; 77(23):6562-6575. PubMed ID: 29021137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Henryin, an ent-kaurane diterpenoid, inhibits Wnt signaling through interference with β-catenin/TCF4 interaction in colorectal cancer cells.
    Li X; Pu J; Jiang S; Su J; Kong L; Mao B; Sun H; Li Y
    PLoS One; 2013; 8(7):e68525. PubMed ID: 23844215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MENA is a transcriptional target of the Wnt/beta-catenin pathway.
    Najafov A; Seker T; Even I; Hoxhaj G; Selvi O; Ozel DE; Koman A; Birgül-İyison N
    PLoS One; 2012; 7(5):e37013. PubMed ID: 22615875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
    Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
    Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.